Author Archives: simewordpress

SIME begins clinical trial validating point-of-care device that rapidly predicts neonatal respiratory disease at birth in the NICU

The FAST 2 (Fourier-transform Infrared Spectroscopy guided Surfactant Therapy) trial begins in 4 Danish University [...]

SIME AI device that predicts acute respiratory disease receives CE Mark – changing the standard of care for millions of babies worldwide

The point-of-care device, which predicts severe lung disease in the ICU and NICU, has been CE [...]

SIME strengthens board to prepare for commercialisation

Morten Henneveld, a life science executive with decades of commercial and operations experience, joins SIME [...]